nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0457	0.0457	CbGpPWpGaD
Mivacurium—CHRNA1—ErbB2/ErbB3 signaling events—PRKACA—adrenal gland cancer	0.0398	0.0398	CbGpPWpGaD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0389	0.0389	CbGpPWpGaD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0369	0.0369	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0344	0.0344	CbGpPWpGaD
Mivacurium—CHRNA1—ErbB2/ErbB3 signaling events—CDC42—adrenal gland cancer	0.0337	0.0337	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0292	0.0292	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0278	0.0278	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—KCNJ5—adrenal gland cancer	0.0263	0.0263	CbGpPWpGaD
Mivacurium—CHRNA1—ErbB2/ErbB3 signaling events—BAD—adrenal gland cancer	0.0236	0.0236	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—KCNJ5—adrenal gland cancer	0.0224	0.0224	CbGpPWpGaD
Mivacurium—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.0221	0.0221	CbGpPWpGaD
Mivacurium—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0219	0.0219	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0213	0.0213	CbGpPWpGaD
Mivacurium—BCHE—Peptide hormone metabolism—REN—adrenal gland cancer	0.0191	0.0191	CbGpPWpGaD
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0175	0.0175	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0153	0.0153	CbGpPWpGaD
Mivacurium—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0149	0.0149	CbGpPWpGaD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0149	0.0149	CbGpPWpGaD
Mivacurium—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0148	0.0148	CbGpPWpGaD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0142	0.0142	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0132	0.0132	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0124	0.0124	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—KCNJ5—adrenal gland cancer	0.0117	0.0117	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0111	0.0111	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0106	0.0106	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—PRKACA—adrenal gland cancer	0.0101	0.0101	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00969	0.00969	CbGpPWpGaD
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00944	0.00944	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—PRKACA—adrenal gland cancer	0.00858	0.00858	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00823	0.00823	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00815	0.00815	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—PRKACA—adrenal gland cancer	0.00815	0.00815	CbGpPWpGaD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00803	0.00803	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00785	0.00785	CbGpPWpGaD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00763	0.00763	CbGpPWpGaD
Mivacurium—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00762	0.00762	CbGpPWpGaD
Mivacurium—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00745	0.00745	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0071	0.0071	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00666	0.00666	CbGpPWpGaD
Mivacurium—BCHE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00635	0.00635	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00627	0.00627	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00621	0.00621	CbGpPWpGaD
Mivacurium—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00617	0.00617	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00603	0.00603	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00587	0.00587	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00573	0.00573	CbGpPWpGaD
Mivacurium—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00571	0.00571	CbGpPWpGaD
Mivacurium—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00566	0.00566	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00545	0.00545	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—BRAF—adrenal gland cancer	0.00544	0.00544	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00493	0.00493	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00488	0.00488	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00485	0.00485	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0048	0.0048	CbGpPWpGaD
Mivacurium—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00463	0.00463	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—BRAF—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Mivacurium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00459	0.00459	CbGpPWpGaD
Mivacurium—BCHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00453	0.00453	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—PRKACA—adrenal gland cancer	0.0045	0.0045	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0044	0.0044	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—BRAF—adrenal gland cancer	0.00439	0.00439	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00435	0.00435	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00376	0.00376	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00372	0.00372	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—REN—adrenal gland cancer	0.0036	0.0036	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00354	0.00354	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00351	0.00351	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00349	0.00349	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00335	0.00335	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00331	0.00331	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—SDHB—adrenal gland cancer	0.00323	0.00323	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00322	0.00322	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00319	0.00319	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00318	0.00318	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00316	0.00316	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00308	0.00308	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00305	0.00305	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00249	0.00249	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—BRAF—adrenal gland cancer	0.00242	0.00242	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—RRM1—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—SDHD—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MED12—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—POMC—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PRKACA—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000999	0.000999	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00099	0.00099	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000954	0.000954	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000945	0.000945	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GNAS—adrenal gland cancer	0.000918	0.000918	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ABCB1—adrenal gland cancer	0.000901	0.000901	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000871	0.000871	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000856	0.000856	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000741	0.000741	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000734	0.000734	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000728	0.000728	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000721	0.000721	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000706	0.000706	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000693	0.000693	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000673	0.000673	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000666	0.000666	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—POMC—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000612	0.000612	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000595	0.000595	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.00059	0.00059	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.00059	0.00059	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000585	0.000585	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000576	0.000576	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00057	0.00057	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000496	0.000496	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—adrenal gland cancer	0.000493	0.000493	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000491	0.000491	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000475	0.000475	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000431	0.000431	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000427	0.000427	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000397	0.000397	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000394	0.000394	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000392	0.000392	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000389	0.000389	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.00038	0.00038	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000379	0.000379	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000377	0.000377	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000284	0.000284	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000281	0.000281	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000225	0.000225	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000223	0.000223	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000189	0.000189	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000187	0.000187	CbGpPWpGaD
